GOSS stock news
This page provides real-time market news, earnings updates, and company announcements related to Gossamer Bio, Inc. (GOSS).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-05 11:53 EST
Gossamer Bio Inc. (Ticker: GOSS) recently disclosed the topline data from its Phase III clinical trial, the Prosera study.
老虎证券2026-02-23 13:28:12
Qualcomm, Booking Holdings receive upgrades: Leading analyst picks from Wall Street
101 finance2026-02-24 14:45:35
Gossamer Bio (GOSS) Reports Topline Phase 3 Results for Seralutinib in Pulmonary Arterial Hypertension
Finviz2026-02-25 10:54:06
GOSS stock chart
GOSS stock detailsGOSS stock price change
On the last trading day, GOSS stock closed at 0.59 USD, with a price change of 25.06% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more